Anticancer Research · 2019 · 16 citations · 8 references
PharmacyMedicinal ChemistryPharmacologyCancer PharmacologyDrug DiscoveryStructure-activity RelationshipsPharmacodynamics Of Anticancer AgentsStructure-activity Relationship AnalysisAnticancer ActivityApoptosis InductionBiological Activity FeaturesCell Cycle AnalysisChemical Structure-activity RelationshipsCytotoxicity AssaysPhysicochemical DescriptorsSubstituent Effects On Biological Activity
BACKGROUND/AIM: Very few studies are available about the biological activity of 3-styrylchromones. Our previous study demonstrated the importance of methoxy group at 6-position of the chromone ring and hydroxyl group at 4'-position of phenyl group in styryl moiety. As a sequel of this study, we synthesized fourteen compounds that include eight 3-styrylchromones where methoxy group was introduced at 7-position of chromone rings, and then evaluated their tumor-specificity. MATERIALS AND METHODS: Tumor-specificity (TS) was calculated by relative cytotoxicity against human oral squamous cell carcinoma cell lines versus human normal oral cells. Apoptosis induction and growth arrest were monitored by cell-cycle analysis. Quantitative structure-activity relationship analysis of TS was performed with 3,167 chemical descriptors. RESULTS AND DISCUSSION: ] showed higher tumor-specificity than doxorubicin and 5-FU, suggesting the importance of methoxy group in 7-position of the chromone ring. These compounds induced the apoptosis and mitotic arrest in HSC-2 cells. The tumor-specificity of 3-styrylchromone derivatives were most correlated with descriptors for molecule shape and electronic charge. The present study suggested that modification by introducing methoxy group at 7-position, instead at 6-position, further increased the tumor-specificity of 3-styrylchromone.
8
Quantitative Structure–Cytotoxicity Relationship of 2-Styrylchromones
Yoshihiro Uesawa, Junko Nagai, Haixia Shi et al. · Anticancer Research · 2019 · 38 citations · Full text